Titre : Hyperthermie provoquée

Hyperthermie provoquée : Questions médicales fréquentes

Termes MeSH sélectionnés :

Asthma
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hyperthermie provoquée : Questions médicales les plus fréquentes", "headline": "Hyperthermie provoquée : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hyperthermie provoquée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-20", "dateModified": "2025-03-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hyperthermie provoquée" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Thérapeutique", "url": "https://questionsmedicales.fr/mesh/D013812", "about": { "@type": "MedicalCondition", "name": "Thérapeutique", "code": { "@type": "MedicalCode", "code": "D013812", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Psammothérapie", "alternateName": "Ammotherapy", "url": "https://questionsmedicales.fr/mesh/D000646", "about": { "@type": "MedicalCondition", "name": "Psammothérapie", "code": { "@type": "MedicalCode", "code": "D000646", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.565.020" } } }, { "@type": "MedicalWebPage", "name": "Diathermie", "alternateName": "Diathermy", "url": "https://questionsmedicales.fr/mesh/D003972", "about": { "@type": "MedicalCondition", "name": "Diathermie", "code": { "@type": "MedicalCode", "code": "D003972", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.565.280" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ultrasonothérapie", "alternateName": "Ultrasonic Therapy", "url": "https://questionsmedicales.fr/mesh/D014464", "about": { "@type": "MedicalCondition", "name": "Ultrasonothérapie", "code": { "@type": "MedicalCode", "code": "D014464", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.565.280.945" } } } ] }, { "@type": "MedicalWebPage", "name": "Chimiothérapie hyperthermique intrapéritonéale", "alternateName": "Hyperthermic Intraperitoneal Chemotherapy", "url": "https://questionsmedicales.fr/mesh/D000084262", "about": { "@type": "MedicalCondition", "name": "Chimiothérapie hyperthermique intrapéritonéale", "code": { "@type": "MedicalCode", "code": "D000084262", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.565.370" } } }, { "@type": "MedicalWebPage", "name": "Bain de vapeur", "alternateName": "Steam Bath", "url": "https://questionsmedicales.fr/mesh/D029002", "about": { "@type": "MedicalCondition", "name": "Bain de vapeur", "code": { "@type": "MedicalCode", "code": "D029002", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.565.640" } } } ], "about": { "@type": "MedicalCondition", "name": "Hyperthermie provoquée", "alternateName": "Hyperthermia, Induced", "code": { "@type": "MedicalCode", "code": "D006979", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mohammad-Amin Abdollahifar", "url": "https://questionsmedicales.fr/author/Mohammad-Amin%20Abdollahifar", "affiliation": { "@type": "Organization", "name": "Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: abdollahima@sbmu.ac.ir." } }, { "@type": "Person", "name": "Abbas Aliaghaei", "url": "https://questionsmedicales.fr/author/Abbas%20Aliaghaei", "affiliation": { "@type": "Organization", "name": "Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran." } }, { "@type": "Person", "name": "Jon E Sprague", "url": "https://questionsmedicales.fr/author/Jon%20E%20Sprague", "affiliation": { "@type": "Organization", "name": "The Ohio Attorney General's Center for the Future of Forensic Science, USA. Electronic address: jesprag@bgsu.edu." } }, { "@type": "Person", "name": "Amir Raoofi", "url": "https://questionsmedicales.fr/author/Amir%20Raoofi", "affiliation": { "@type": "Organization", "name": "Leishmaniasis Research Center, Department of Anatomy, Sabzevar University of Medical Sciences, Sabzevar, Iran." } }, { "@type": "Person", "name": "Shabnam Abdi", "url": "https://questionsmedicales.fr/author/Shabnam%20Abdi", "affiliation": { "@type": "Organization", "name": "Department of Anatomical Sciences & Cognitive Neuroscience, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Phenotype of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35916048", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3346/jkms.2022.37.e236" } }, { "@type": "ScholarlyArticle", "name": "Consensus document on asthma and smoking of the Regional Asthma Forum of SEPAR.", "datePublished": "2023-01-01", "url": "https://questionsmedicales.fr/article/34171114", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.20882/adicciones.1583" } }, { "@type": "ScholarlyArticle", "name": "The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control.", "datePublished": "2023-04-25", "url": "https://questionsmedicales.fr/article/37105501", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.anai.2023.04.024" } }, { "@type": "ScholarlyArticle", "name": "Asthma control in severe asthma and occupational exposures to inhalable asthmagens.", "datePublished": "2024-09-30", "url": "https://questionsmedicales.fr/article/39349306", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjresp-2023-001943" } }, { "@type": "ScholarlyArticle", "name": "Delineating asthma according to inflammation phenotypes with a focus on paucigranulocytic asthma.", "datePublished": "2023-07-05", "url": "https://questionsmedicales.fr/article/37185590", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/CM9.0000000000002456" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Thérapeutique", "item": "https://questionsmedicales.fr/mesh/D013812" }, { "@type": "ListItem", "position": 3, "name": "Hyperthermie provoquée", "item": "https://questionsmedicales.fr/mesh/D006979" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hyperthermie provoquée - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hyperthermie provoquée", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hyperthermie provoquée", "description": "Comment diagnostiquer l'hyperthermie provoquée ?\nQuels tests sont utilisés pour confirmer l'hyperthermie ?\nQuels signes cliniques indiquent une hyperthermie ?\nL'hyperthermie est-elle toujours dangereuse ?\nComment différencier l'hyperthermie de la fièvre ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Asthma&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hyperthermie provoquée", "description": "Quels sont les symptômes de l'hyperthermie provoquée ?\nL'hyperthermie provoquée cause-t-elle des douleurs ?\nPeut-on avoir des troubles de la conscience ?\nY a-t-il des signes cutanés associés ?\nL'hyperthermie provoquée affecte-t-elle la respiration ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Asthma&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hyperthermie provoquée", "description": "Comment prévenir l'hyperthermie provoquée ?\nLes vêtements influencent-ils l'hyperthermie ?\nFaut-il surveiller la température corporelle ?\nLes pauses sont-elles importantes ?\nL'alimentation joue-t-elle un rôle ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Asthma&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hyperthermie provoquée", "description": "Comment traiter l'hyperthermie provoquée ?\nDes médicaments sont-ils nécessaires ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il consulter un médecin ?\nLe repos est-il recommandé ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Asthma&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hyperthermie provoquée", "description": "Quelles complications peuvent survenir ?\nL'hyperthermie peut-elle être mortelle ?\nQuels organes sont les plus affectés ?\nDes séquelles peuvent-elles persister ?\nComment éviter les complications graves ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Asthma&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hyperthermie provoquée", "description": "Qui est le plus à risque d'hyperthermie ?\nL'exercice augmente-t-il le risque ?\nLes médicaments influencent-ils le risque ?\nL'humidité joue-t-elle un rôle ?\nLe surpoids est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Asthma&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hyperthermie provoquée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique et la mesure de la température corporelle." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer l'hyperthermie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des évaluations physiologiques peuvent être réalisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une hyperthermie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent une température élevée, des frissons et une confusion mentale." } }, { "@type": "Question", "name": "L'hyperthermie est-elle toujours dangereuse ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, elle peut être contrôlée, mais nécessite une surveillance." } }, { "@type": "Question", "name": "Comment différencier l'hyperthermie de la fièvre ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'hyperthermie est causée par des facteurs externes, alors que la fièvre est une réponse immunitaire." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hyperthermie provoquée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges, des maux de tête et une confusion." } }, { "@type": "Question", "name": "L'hyperthermie provoquée cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des douleurs musculaires et des crampes." } }, { "@type": "Question", "name": "Peut-on avoir des troubles de la conscience ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la conscience peuvent survenir en cas d'hyperthermie sévère." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des rougeurs ou des éruptions cutanées peuvent apparaître en cas d'hyperthermie." } }, { "@type": "Question", "name": "L'hyperthermie provoquée affecte-t-elle la respiration ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner une respiration rapide et superficielle." } }, { "@type": "Question", "name": "Comment prévenir l'hyperthermie provoquée ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les environnements chauds et hydratez-vous régulièrement lors d'activités physiques." } }, { "@type": "Question", "name": "Les vêtements influencent-ils l'hyperthermie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, porter des vêtements légers et respirants aide à prévenir l'hyperthermie." } }, { "@type": "Question", "name": "Faut-il surveiller la température corporelle ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, surveiller la température est essentiel lors d'activités à risque." } }, { "@type": "Question", "name": "Les pauses sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, prendre des pauses régulières lors d'activités physiques intenses est crucial." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée aide à maintenir une bonne régulation thermique." } }, { "@type": "Question", "name": "Comment traiter l'hyperthermie provoquée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut le refroidissement du corps et l'hydratation adéquate." } }, { "@type": "Question", "name": "Des médicaments sont-ils nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être administrés pour soulager les symptômes associés." } }, { "@type": "Question", "name": "Quelle est l'importance de l'hydratation ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "L'hydratation est cruciale pour prévenir des complications graves liées à l'hyperthermie." } }, { "@type": "Question", "name": "Quand faut-il consulter un médecin ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin si les symptômes persistent ou s'aggravent malgré le traitement." } }, { "@type": "Question", "name": "Le repos est-il recommandé ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le repos est essentiel pour permettre au corps de récupérer." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des coups de chaleur, des défaillances organiques et des convulsions." } }, { "@type": "Question", "name": "L'hyperthermie peut-elle être mortelle ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une hyperthermie sévère non traitée peut entraîner la mort." } }, { "@type": "Question", "name": "Quels organes sont les plus affectés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le cerveau, le cœur et les reins sont particulièrement vulnérables à l'hyperthermie." } }, { "@type": "Question", "name": "Des séquelles peuvent-elles persister ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquelles neurologiques peuvent persister après une hyperthermie sévère." } }, { "@type": "Question", "name": "Comment éviter les complications graves ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement rapide et approprié est essentiel pour éviter les complications graves." } }, { "@type": "Question", "name": "Qui est le plus à risque d'hyperthermie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées, les enfants et celles avec des maladies chroniques sont plus à risque." } }, { "@type": "Question", "name": "L'exercice augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice intense dans des environnements chauds augmente le risque d'hyperthermie." } }, { "@type": "Question", "name": "Les médicaments influencent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent altérer la régulation thermique et augmenter le risque." } }, { "@type": "Question", "name": "L'humidité joue-t-elle un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une humidité élevée augmente le risque d'hyperthermie en réduisant l'évaporation de la sueur." } }, { "@type": "Question", "name": "Le surpoids est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le surpoids peut augmenter le risque d'hyperthermie en réduisant l'efficacité de la thermorégulation." } } ] } ] }

Sources (6562 au total)

Phenotype of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts.

Asthma and chronic obstructive pulmonary disease (COPD) are airway diseases with similar clinical manifestations, despite differences in pathophysiology. Asthma-COPD overlap (ACO) is a condition chara... Patients with COPD were prospectively enrolled into the Korean COPD subgroup study (KOCOSS) cohort. Patients with severe asthma were prospectively enrolled into the Korean Severe Asthma Registry (KoSA... The prevalence of ACO significantly differed between the COPD and severe asthma cohorts (19.8% [365/1,839] vs. 12.5% [104/832], respectively;... The prevalence of ACO differed between COPD and severe asthma cohorts. ACO patients can be classified into four phenotype groups, such that each phenotype exhibits distinct characteristics....

The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control.

Asthma control is often overestimated in routine practice, and despite advances in the understanding of immunopathology and the availability of new precision therapies, the burden of disease remains u... To compare the performance of the Asthma Impairment and Risk Questionnaire (AIRQ) with patient and physician assessments and the Asthma Control Test (ACT) in identifying asthma control.... Baseline data from a longitudinal study of the AIRQ were analyzed. Patients with asthma in the United States aged 12 years and older followed in 24 specialty practices and 1 specialty-affiliated prima... A total of 1112 participants were enrolled (mean [SD] age = 43.9 [19.3] years, 70% of the female sex, 78% White). Overall, 62% of participants rated themselves as well- or completely controlled, and 5... The burden of asthma is substantial in patients cared for by asthma specialists, and asthma control is overestimated by patients, physicians, and the symptom-based ACT. The AIRQ assesses risk in addit...

Asthma control in severe asthma and occupational exposures to inhalable asthmagens.

Work-related asthma accounts for ≥25% of asthma in working-age populations, though the relationship between work exposures and symptoms is frequently missed, leading to poor health and employment outc... We searched the Birmingham (UK) Regional NHS SA Service clinical database (n=1453 records; 1 March 2004 to 1 March 2021) and undertook a cross-sectional study using baseline data collected at diagnosi... Frequently reported occupations were care assistants (7%) and nurses (6%); 197/504 (39%) patients were exposed to an asthmagen, including respiratory sensitisers (30%), airway irritants (38%) and clea... JEM-determined workplace exposures to inhaled asthmagens are not associated with asthma control in SA; 29-39% of patients may have current exposure to workplace asthmagens. Routine collection of lifet...

A prediction model for asthma exacerbations after stopping asthma biologics.

Little is known regarding the prediction of the risks of asthma exacerbation after stopping asthma biologics.... To develop and validate a predictive model for the risk of asthma exacerbations after stopping asthma biologics using machine learning models.... We identified 3057 people with asthma who stopped asthma biologics in the OptumLabs Database Warehouse and considered a wide range of demographic and clinical risk factors to predict subsequent outcom... The mean age of the total cohort was 47.1 (SD, 17.1) years, 1859 (60.8%) were women, 2261 (74.0%) were White, and 1475 (48.3%) were in the Southern region of the United States. The elastic-net logisti... Outcomes after stopping asthma biologics can be predicted with moderate accuracy using machine learning methods....

Nonrespiratory Diseases in Adults Without and With Asthma by Age at Asthma Diagnosis.

Chronic nonrespiratory diseases are seemingly more prevalent in subjects with than without asthma, and asthma seems to differentiate by age of onset. However, studies with comparison of nonrespiratory... To compare the quantity and type of chronic nonrespiratory diseases in adults with and without asthma considering age at asthma diagnosis.... In 2016, a FinEsS questionnaire was sent to 16,000 20- to 69-year-old adults randomly selected in Helsinki and Western Finland populations. Physician-diagnosed asthma was categorized to early (0-11), ... A total of 8199 (51.5%) responded, and 842 (10.3%) reported asthma and age at diagnosis. In age and sex-adjusted binary logistic regression model, the most represented nonrespiratory disease was treat... Nonrespiratory diseases were more common in adults with asthma than in adults without asthma. The type of nonrespiratory diseases differed, and their frequency increased by increasing age at asthma di...

Correlation between impulse oscillometry parameters and test for respiratory and asthma control in kids (TRACK) in asthma control of preschoolers with asthma.

Little research has been conducted to evaluate the correlation between impulse oscillometry (IOS), Childhood Asthma Control Test (C-ACT), and Test for Respiratory and Asthma Control in Kids (TRACK).... This study was conducted at China Medical University Hospital between September 1, 2019, and March 31, 2021. Children aged 2-6 years who had been diagnosed with asthma with acute exacerbation were enr... A total of 114 children with asthma and acute exacerbations were recruited. Their mean age was 4.1 ± 1.1 years, and 60.5% were males. After a year of treatment, the change of R5-R20 from baseline 0.64... TRACK score appears to have a stronger association with the IOS parameter than C-ACT score. Our findings indicate that TRACK is a valid tool for assessing asthma control in preschool children....

Picturing asthma in Turkey: results from the Turkish adult asthma registry.

National data on asthma characteristics and the factors associated with uncontrolled asthma seem to be necessary for every country. For this purpose, we developed the Turkish Adult Asthma Registry for... Case entries were performed between March 2018 and March 2022. A web-based application was used to record data. Study outcomes were demographic features, disease characteristics, asthma control levels... The registry included 2053 patients from 36 study centers in Turkey. Female subjects dominated the group (... The picture of this registry showed a dominancy of middle-aged obese women with moderate-to-severe asthma. We also determined particular strategic targets such as low educational level, severe asthma ...